571 related articles for article (PubMed ID: 25536015)
21. Mass spectrometry-based proteomic analysis of Leishmania donovani soluble proteins in Indian clinical isolate.
Kumar A; Misra P; Sisodia B; Shasany AK; Sundar S; Dube A
Pathog Dis; 2014 Feb; 70(1):84-7. PubMed ID: 24115687
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.
Zhang WW; Matlashewski G
Mol Microbiol; 2001 Feb; 39(4):935-48. PubMed ID: 11251814
[TBL] [Abstract][Full Text] [Related]
23. Leishmania donovani hybridisation and introgression in nature: a comparative genomic investigation.
Lypaczewski P; Matlashewski G
Lancet Microbe; 2021 Jun; 2(6):e250-e258. PubMed ID: 35544170
[TBL] [Abstract][Full Text] [Related]
24. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
25. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.
Matte C; Olivier M
J Infect Dis; 2002 Mar; 185(5):673-81. PubMed ID: 11865425
[TBL] [Abstract][Full Text] [Related]
26. Determinants for the development of visceral leishmaniasis disease.
McCall LI; Zhang WW; Matlashewski G
PLoS Pathog; 2013 Jan; 9(1):e1003053. PubMed ID: 23300451
[TBL] [Abstract][Full Text] [Related]
27. Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania.
Nandan D; Zhang N; Yu Y; Schwartz B; Chen S; Kima PE; Reiner NE
PLoS One; 2018; 13(11):e0206920. PubMed ID: 30399177
[TBL] [Abstract][Full Text] [Related]
28. The emergence of Leishmania major and Leishmania donovani in southern Turkey.
Koltas IS; Eroglu F; Alabaz D; Uzun S
Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):154-8. PubMed ID: 24449479
[TBL] [Abstract][Full Text] [Related]
29. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
Tonui WK; Titus RG
Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
[TBL] [Abstract][Full Text] [Related]
30. Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance.
Zheng Z; Chen J; Ma G; Satoskar AR; Li J
Parasit Vectors; 2020 Oct; 13(1):510. PubMed ID: 33046138
[TBL] [Abstract][Full Text] [Related]
31. The protein map of the protozoan parasite Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis and Leishmania (Leishmania) infantum during growth phase transition and temperature stress.
Mule SN; Saad JS; Sauter IP; Fernandes LR; de Oliveira GS; Quina D; Tano FT; Brandt-Almeida D; Padrón G; Stolf BS; Larsen MR; Cortez M; Palmisano G
J Proteomics; 2024 Mar; 295():105088. PubMed ID: 38237666
[TBL] [Abstract][Full Text] [Related]
32. Leishmania donovani and cutaneous leishmaniasis, Sri Lanka.
Siriwardana HV; Noyes HA; Beeching NJ; Chance ML; Karunaweera ND; Bates PA
Emerg Infect Dis; 2007 Mar; 13(3):476-8. PubMed ID: 17552105
[TBL] [Abstract][Full Text] [Related]
33. Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains.
Gutiérrez-Corbo C; Domínguez-Asenjo B; Pérez-Pertejo Y; García-Estrada C; Bello FJ; Balaña-Fouce R; Reguera RM
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010170. PubMed ID: 35139072
[TBL] [Abstract][Full Text] [Related]
34. Concurrent infection with Leishmania donovani and Leishmania major in a Kenyan patient: clinical description and parasite characterization.
Mebrahtu YB; Lawyer PG; Hendricks LD; Muigai R; Oster CN; Perkins PV; Koech DK; Pamba H; Roberts CR
Am J Trop Med Hyg; 1991 Sep; 45(3):290-6. PubMed ID: 1928563
[TBL] [Abstract][Full Text] [Related]
35. A proteogenomic approach to map the proteome of an unsequenced pathogen - Leishmania donovani.
Pawar H; Sahasrabuddhe NA; Renuse S; Keerthikumar S; Sharma J; Kumar GS; Venugopal A; Sekhar NR; Kelkar DS; Nemade H; Khobragade SN; Muthusamy B; Kandasamy K; Harsha HC; Chaerkady R; Patole MS; Pandey A
Proteomics; 2012 Mar; 12(6):832-44. PubMed ID: 22539434
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiology of leishmaniasis in Asia (focus on cutaneous infections).
Katakura K
Curr Opin Infect Dis; 2009 Apr; 22(2):126-30. PubMed ID: 19276879
[TBL] [Abstract][Full Text] [Related]
37. Concomitant natural infection with L. donovani and L. major: a case report from Iraq.
al-Diwany LJ; al-Awkati NA; Atia M; Rassam MB
Soz Praventivmed; 1995; 40(4):234-8. PubMed ID: 8525713
[TBL] [Abstract][Full Text] [Related]
38. Leishmania mini-exon genes for molecular epidemiology of leishmaniasis in China and Ecuador.
Katakura K; Kawazu SI; Sanjyoba C; Naya T; Matsumoto Y; Ito M; Nagakura K; Aikawa M; Hashiguchi Y
Tokai J Exp Clin Med; 1998 Dec; 23(6):393-9. PubMed ID: 10622637
[TBL] [Abstract][Full Text] [Related]
39. Moving from unsequenced to sequenced genome: reanalysis of the proteome of Leishmania donovani.
Nirujogi RS; Pawar H; Renuse S; Kumar P; Chavan S; Sathe G; Sharma J; Khobragade S; Pande J; Modak B; Prasad TS; Harsha HC; Patole MS; Pandey A
J Proteomics; 2014 Jan; 97():48-61. PubMed ID: 23665000
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analyses of membrane enriched proteins of Leishmania donovani Indian clinical isolate by mass spectrometry.
Kumar A; Misra P; Sisodia B; Shasany AK; Sundar S; Dube A
Parasitol Int; 2015 Aug; 64(4):36-42. PubMed ID: 25597695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
